Stevens Andrew R, Soon Wai C, Chowdhury Yasir A, Toman Emma, Yim Sebastian, Veenith Tonny, Chelvarajah Ramesh, Belli Antonio, Davies David
Neurosurgery, University Hospitals Birmingham, Birmingham, GBR.
National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre, University Hospitals Birmingham, Birmingham, GBR.
Cureus. 2022 Oct 7;14(10):e30033. doi: 10.7759/cureus.30033. eCollection 2022 Oct.
Considerable variation exists in the clinical practice of cerebrospinal fluid diversion for medically refractory intracranial hypertension in patients with acute traumatic brain injury (TBI), which is achievable via lumbar or ventricular drainage. This systematic review sought to compile the available evidence for the efficacy and safety of the use of lumbar drains for intracranial pressure (ICP) control. A systematic review of the literature was performed with the search and data extraction performed by two reviewers independently in duplicate. Nine independent studies were identified, enrolling 230 patients, 159 with TBI. Efficacy for ICP control was observed across all studies, with immediate and sustained effect, reducing medical therapy requirements. Lumbar drainage with medical therapy appears effective when used alone and as an adjunct to ventricular drainage. Safety reporting varied in quality. Clinical or radiological incidents of cerebral herniation (with an unclear relationship to lumbar drainage) were observed in 14/230 patients resulting in one incident of morbidity without adverse patient outcome. The available data is generally poor in quality and volume, but supportive of the efficacy of lumbar drainage for ICP control. Few reports of adverse outcomes are suggestive of, but are insufficient to confirm, the safety of use in the appropriate patient and clinical setting. Further large prospective observational studies are required to generate sufficient support of an acceptable safety profile.
对于急性创伤性脑损伤(TBI)患者因药物难治性颅内高压而进行的脑脊液引流临床实践存在很大差异,可通过腰椎或脑室引流实现。本系统评价旨在汇总使用腰椎引流控制颅内压(ICP)的有效性和安全性的现有证据。对文献进行了系统评价,检索和数据提取由两名评价者独立重复进行。确定了9项独立研究,纳入230例患者,其中159例为TBI患者。所有研究均观察到控制ICP的有效性,具有即时和持续效果,减少了药物治疗需求。腰椎引流联合药物治疗单独使用以及作为脑室引流的辅助手段似乎有效。安全性报告质量参差不齐。在14/230例患者中观察到脑疝的临床或放射学事件(与腰椎引流的关系不明确),导致1例发病事件但患者无不良结局。现有数据的质量和数量普遍较差,但支持腰椎引流控制ICP的有效性。关于不良结局的报告很少,提示但不足以证实其在合适患者和临床环境中的使用安全性。需要进一步开展大型前瞻性观察性研究,以充分支持可接受的安全性概况。